Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Alcoholic Liver Disease

In brief

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.

Key facts

Study ID

NCT04320199

Run by

Pusan National University Yangsan Hospital

People needed

30

Starts

2020-01-01

Expected to finish

2025-12-31

Last updated by the study team

2025-06-04

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Gamma-glutamyl transferase ranging from upper limit of reference to four times of upper limit

You may not qualify if…

• Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
• Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
• History of viral hepatitis or cancer
• Uncontrolled hypertension
• History of serious cardiac disease such as angina or myocardial infarction
• History of gastrectomy
• History of medication for psychiatric disease
• Administration of oriental medicine including herbs within the past 4 weeks

Where it is running

• Pusan National University Yangsan Hospital — Pusan, Ami-dong, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.